Financials

News Ideas Technicals Forecast

LYEL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Lyell Immunopharma, Inc.

Total assets of LYEL for Q1 24 is 694.22 M USD, 7.44% less than the previous Q4 23. And total liabilities decreased by 4.22% in Q1 24 to 91.06 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—